Nelson Jennifer Ann

Omega Therapeutics, Inc. · Chief Scientific Officer

Nelson Jennifer Ann is listed in filings as Chief Scientific Officer at Omega Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 26, 2024, including 1 public disclosure. Recent filings connect the profile to Omega Therapeutics, Inc. (OMGA). The current snapshot covers public activity from Nov 26, 2024. Reported amounts are shown as $86.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.